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Background. Our aim was to describe the steps in planning, implementing, and running a multicentre cohort study of maternal
and perinatal health using a high-quality biobank comprised of maternal serum, plasma, and hair samples collected from five sites
in Brazil. The Preterm SAMBA study, conducted by the Brazilian Network for Studies on Reproductive and Perinatal Health, was
an innovative approach used to identify women at higher risk for preterm birth. It is also of great importance in the study of other
maternal and perinatal complications in the context of Brazil, which is a middle-income country. Methods. We described phases
of planning, implementing, and running the Preterm SAMBA study, a multicentre Brazilian cohort study of low-risk nulliparous
pregnant women, to validate a set of metabolite biomarkers for preterm birth identified in an external cohort. Procedures and
strategies used to plan, implement, and maintain this multicentre preterm birth study are described in detail. Barriers and
experience cited in the current narrative are not usually discussed in the scientific literature or published study protocols. Results.
Several barriers and strategies were identified in different phases of the Preterm SAMBA study at different levels of the study
framework (steering committee; coordinating and local centres). Strategies implemented and resources used in the study are a legacy
of the Brazilian Network, aimed at training collaborators in such complex settings. Conclusion. The Brazilian Network for Studies
on Reproductive and Perinatal Health has gained some experience in conducting a multicentre cohort study using a resourceful
biobank which may be helpful to other research groups and maternal/perinatal health networks that plan on employing a similar
approach to a similar background.
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1. Background
The Brazilian Network for Studies on Reproductive and
Perinatal Health (BNSRPH) is a national research initiative
that has enabled a number of multicentre studies within the
country. It has had a major impact on maternal and perinatal
health in the last decade [1–4]. The BNSRPH was officially
launched in 2008, when twenty-seven institutions from five
regions of Brazil agreed to participate in the first multicentre
study coordinated by this network. These institutions were
provided with funding to perform surveillance of severe
maternalmorbidity [5–7]. For the conception of this Brazilian
initiative [5], it was particularly important to have experi-
ence as partners and data collectors in multicentre studies
headed by international initiatives such as the University of
Cincinnati, USA [8], and most importantly the University of
Toronto, Canada [9].
Experience and effectiveness of epidemiological studies
have evolved to the possibility of scaling up and planning
studies that meet translational research requirements. It
is an approach to propose interventions that may have a
potential impact on maternal and perinatal health. Current
infrastructure has enabled adequate clinical data collection,
along with biological sample storage. The Preterm SAMBA
project represents this initiative.
The Preterm SAMBA cohort study (Preterm Screening
and Metabolomics in Brazil and Auckland) enrolled around
1,150 low-risk nulliparous pregnant women from 5 different
Brazilian centres. Participants received follow-up care at
three study visits during pregnancy (20, 27, and 37th weeks
gestation). Blood and hair samples were collected at 20 weeks
of gestational age (+/- 1wk). Comprehensive clinical data
including blood pressure levels, BMI (body mass index),
medical history, clinical complications such as infectious dis-
eases, ultrasound data, and maternal and perinatal outcomes
were standardised, collected, and recorded online in an elec-
tronic database. Biological samples were collected, processed,
and immediately stored in the laboratory, under specific
conditions and following a very precise operational biobank
protocol [4]. The main objective was to validate biological
predictors of preterm birth based on the metabolomics
approach.
Planning, implementing, and running a multicentre
preterm birth study with biobank resources in Brazil repre-
sents a challenge that should be acknowledged. Experience
that is not always reported in research protocols can serve as
an example, especially in under-resourced settings where dif-
ficulties in pursuing these studies are known to be enormous.
We aim to tackle all issues involved in this initiative.
2. Methods
2.1. Planning. Research projects can only thrive with proper
funding. In 2013, the Preterm SAMBA project proposal was
submitted to a joint research call from the Bill and Melinda
Gates Foundation (BMGF), the Brazilian Ministry of Health
and the Brazilian National Research Council (CNPq), an
agency under the Ministry of Science and Technology. This
grant was part of a program called “Reducing the burden
of preterm birth,, an agenda of shared priorities to address
the occurrence and consequences of preterm birth through
innovative approaches in locations where the burden of
disease is heaviest. At that time, it seemed very appropriate
to form a partnership with international collaboration. The
chosen international group had pioneered the application of
metabolomics technologies in maternal and perinatal health
[10–13] and could help build a very high-quality biobank.
Interestingly, the full proposal of this study was only
developed during the selection process of this research call.
Initially, a 5-page letter of intention was presented and
selected in the first round.Then, a full proposal was presented
for the second round, when a technical examining committee
was in charge of assessing proposals and making recommen-
dations. Finally, in the third round the same committee was
responsible for checking changes in the proposal, according
to previous suggestions and selecting the final grantees. This
process allowed for some improvements in the research
proposal while the selection process was running.
The Preterm SAMBA project aims to develop a predictive
algorithm based on biomarker screening tests (involving
both phases of discovery and validation) that may translate
into clinical care. Ultimately, a panel of biomarkers can be
identified as an early pregnancy screening test to ascertain
which pregnant women are at higher risk of developing
preterm birth (PTB), thus facilitating timely and appropriate
interventions.
2.2. Ethics, Consent and Permission. The establishment of
systematic sample collection and biobank storage requires
compliance with rigorous ethical regulations. Ethical aspects
for biorepository/biobank (Resolution  441/11), sample
transport (Resolution  1306/14), shipping samples abroad
to international partners (Resolution  292/99), and sub-
sequent sample use in future studies/analyses (Resolutions
 347/05 and 441/11) were all regulations considered and
respected.
The first step was to submit the research project to the
Institutional Review Board (IRB) of the coordinating centre
for assessment and approval, followed by its registration in the
Brazilian National Research Registry platform (Plataforma
Brasil), where the project was appreciated by each local
IRB of the remaining participating centres. Ethical approval
was then confirmed by the National Committee for Ethics
in Research (CONEP) through Letter of approval number
912.714 from the IRB of the University of Campinas issued on
12/13/2014. Although the coordinating centre had only most
recently approved its Institutional Biobank by the Brazilian
National Committee for Ethics in Research, the project
started after a biorepository and not a biobank was launched
and established, according to Brazilian regulation. However,
it benefited from Biobank infrastructure, as well as its
technical and human resources, assuring quality control for
all necessary procedures. No other participating institution
where samples were collected and temporarily stored had
obtained formal biobank approval. In this case, the local
PI and not the institution was the curator responsible for
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Figure 1: Framework of Preterm SAMBA study.
the samples and periodical renovation of ethical approval as
required. A clear and elucidative consent form was applied to
all participating women, clarifying that, in addition to trivial
points, part of the samples would be shipped abroad and
future investigations could be conducted using their samples.
It was accepted that these participants could agree partially
or fully. Furthermore, another important aspect of ethical
consideration was the commitment of international partners
to follow Brazilian rules.
The coordinating centre (University of Campinas, UNI-
CAMP) and the steering committee had a major role in the
framework of the study (Figure 1). The steering committee,
represented by the senior investigators of both research
groups, played a significant and strategic role throughout
the project. The committee was responsible for reviewing,
approving and coordinating study data and sample analyses
and supervising study progress. As outlined by the flowchart,
international partnership was initially established with the
University of Auckland, which was hosting the international
PI of the study, Prof. P Baker. Shortly afterwards, our second
international partner was the University of Cork, Ireland,
followed by the University of Leicester, UK.The international
PI had moved to the last location during the study.
The five participating centres were selected according to
previous performance and commitment to the Brazilian net-
work of multicentre studies, minimal existing infrastructure
for biological sample collection and storage, and strategic
geographical location, to address populations of different
cultural and ethnic background. Each participating centre
worked with a local PI and one or more assistant researchers
to cover study requirements for subject enrolment, clinical
follow-up and laboratory procedures. Team selection is par-
ticularly relevant to the development and sustainability of the
study. The commitment of the staff exceeded that foreseen
by the financial support available and was mainly driven by
research interests.
3. Results
The general study manager, based in the coordinating centre
in Brazil, visited the University of Auckland andUniversity of
Cork before implementing the study. Experience and know-
how were shared following standard protocols used in the
SCOPE and IMPROvED studies [14, 15] by the Preterm
SAMBA international partners. It was crucial to standardise
equipment and supplies that would be used in the Brazilian
cohort and develop the Preterm SAMBA Standard Operat-
ing Procedures (SOPs). One week spent at each university
provided the general manager with detailed training in all
steps of data and sample collection, processing and storage.
Overall, this training allowed transfer of expertise from inter-
national partners to the Brazilian team, providing resources
for the development of Case-Report Forms (CRF), database
and protocols for the Preterm Samba Study. Concern about
the temperature control system, institutional adaptation to
biobank monitoring (development of maintenance service
protocols) and emergency protocols for freezer failure were
also considered at this point in time.
Seven different SOPswere designed to standardise several
procedures for all related topics, in addition to registering
and providing detailed information on such procedures. The
following SOPs were created in press and pdf files, with
images, photographs, and print screens and provided to
all assistants and researchers in all participating centres:
(1) Operation Manual: introduction to the database system
and details of its functions; (2) Interviewer: information
on study design, clinical visits, eligibility criteria, invitation
and inclusion procedures, data collection, and definition of
all variables; detailed support guidelines on how to admin-
ister a 24-h dietary recall (with charts on portion size)
and skinfold measurements (with detailed information on
technical procedures); (3) sample collection: detailed infor-
mation about sample collection, biological safety procedures,
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quality control and ethical aspects; (4) sample processing and
storage: detailed information on different steps and quality
control regarding the biorepository; (5) division of biobank
samples: after sample processing, samples from each woman
participating in the Preterm SAMBA study generated serum
and plasma aliquots.
Samples were temporarily stored in the local centres,
and then shipped to the coordinating centre, which was
responsible for dividing the biobank in two—Biobank Brazil
and International Biobank. Aliquots from the international
biobank were shipped to the international project collabo-
rator for use in previously designed research analyses and
also for future discussion by the project steering commit-
tee [4]. Careful safety procedures were employed to avoid
misclassifying aliquot tracking positions, according to the
respective participant and also assure quality control. Such
procedures had to be planned and carried out carefully,
without any haste. Two serum vacutainer tubes, for instance,
were collected from each participant. After processing, serum
samples from the second tube were stored in positions imme-
diately after the first tube. Since the biobank was divided
in two, alternate aliquots were selected for the Brazilian
biobank instead of selecting the first half of the aliquots,
for example. Although tricky, this procedure ensured that
fibrin or haemolysis of one of the serum vacutainers tube
would not compromise the entire Brazilian or Interna-
tional biobank; (6) sample transportation: details on sample
packing, parcel configuration, proportion of boxes/aliquots,
and dry ice and data logger disposal were described. A
certified company in compliance with international rules
and recommendations for biological transport in ultra-low
temperatures was responsible for national and international
sample transport.
3.1. Implementing. The Preterm SAMBA biorepository was
based on the Institutional Biobank of the Maternity Hospital
of the University of Campinas. We believe that institutional
support with technical equipment and human resources
are crucial to establish a high-quality biobank and allow
implementation of the clinical study. A strong commitment of
the institution facilitates the following: (1) general and specific
arrangements for project implementation and progression:
some institutional arrangements are usually required for
project implementation such as private rooms dedicated to
clinical visits and interviews for the study, changes in patient
care workflow, adaptation of routine antenatal care agenda
with activities foreseen in the project (sample collection,
interviews, etc.), and temporary clinical licence for research
assistants (respecting adequate background), allowing their
access to medical records at different sites of the institution;
(2) identification of possible new assistants throughout the
study, to allow for needed reposition: the Brazilian Network
experience showed us that despite an occasional replacement
of research assistants, this may have a huge impact on
study implementation and progress due to possible delays
in identifying new suitable collaborators and the need for
new training sessions and accreditation. Part-time contract
employees from the institution and postgraduate students
linked to the project are the most common assistants that
collaborate with the project. In our opinion, themain barriers
to identify new assistants and the reasons for discontinuation
may be related to the perspective that research collaboration
may require more strict commitment in terms of workload,
quality control, and responsibilities compared to other more
profitable activities.Therefore, adequate funding allocated for
research assistants and availability of institutional staff to con-
duct research activities is a priority of great importance; (3)
optimal use of resources: the acquisition of new equipment or
consumables that will be part of the heritage of the institution
should take into consideration existing infrastructure. After
the end of the study, the institution will be responsible for the
maintenance and supply of consumables.
Some of the equipment and consumables for the biobank
were imported. There were few suppliers that provided new
solutions in biobank technology in Brazil. Cryovials made
of polypropylene, RNase/DNase-free, and pyrogen-free, con-
taining a unique 2-DData-Matrix Bar Code Insert at the bot-
tom of the vial were used to store serum and plasma aliquots.
This technology permits scanning of a whole cryobox with
up to 96 cryovials in less than 10 seconds, saving time, and
minimizing human errors during the process. In addition,
the compact cryobox size results in at least 50% more space
in the freezer when compared to ordinary biobank boxes
available in Brazil. Depending on the configuration of freezer
racks (using low profile racks), space can improve up to 150%.
The timeframe to complete all customs clearance procedures
for imported equipment and consumables can take months,
sometimes years, depending on the item. It is considered a
bureaucratic barrier for the Brazilian scientific community.
In 2004, an alternative to the conventional import procedure
was launched by a joint of Brazilian organisations (the Brazil-
ian official postal service, the Brazilian Ministries of Science,
Technology and Innovation and Finance) termed “Science
Easy Import system.” Although there are some restrictions
on certain items, including value of the commercial invoice,
size and weight of the parcel, etc., the system provides a much
quicker, less bureaucratic, and more suitable operation. We
have translated our experience with the Science Import into
a tutorial document to assist and encourage other researchers
to use the system [16].
For adequate referral of study subjects, the public health
system was strongly involved, raising awareness about the
study. It also developed mechanisms aimed at identifying
eligible cases, especially within primary healthcare, which
was the targeted study population. This strategy was effec-
tive, since participating maternities are referral centres for
high-risk pregnancies. The Brazilian public health system
is decentralised and municipalities provide women with
comprehensive, free and universal access to healthcare [17].
Primary healthcare facilities are crucial to the provision
of medical care. These units are the basis for the entire
healthcare system and a referral for screening. Therefore,
antenatal care for low-risk pregnant women should be pro-
vided at this level of care. During study implementation,
the participating centres arranged local agreements and
obtained respective approval of the municipalities to identify
eligible women seeking prenatal care at primary healthcare
units.
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Figure 2: Enrolment rate of the Preterm SAMBA study. Marks A, B, C, D, and E were remarkable set points of the study. The dashed line
corresponds to the median – 45.0.
All multicentre studies carried out by the Brazilian
Network were launched during the initial meeting for imple-
mentation and training with all research assistants, local PIs,
research collaborators and funders. Although some training
sessions could be organised by webinar meetings, we believe
that the interaction and participation of the whole group can
transform a seminar into amuchmore collaborative meeting,
with a greater commitment of everyone involved. For the
current study, a two-day meeting was held at the University
of Campinas to discuss the final version of an electronic CRF
within the database and potential local adaptation of any
protocol procedure. Furthermore, the study protocol, study
equipment, platform for data collection, and a general view
of SOPs were also introduced. On-site visits prior to the study
were also performed in all participating centres, since sample
collection, processing, and storage training sessions required
hands-on practice.
A test version of the database, very similar to one that is
routinely implemented, was used for training research assis-
tants. In addition, the coordinating centre arranged webinars
to discuss more detailed information on the definition of
variables and monitored data entered by assistants in the
test database during the training period. Only then would
the assistants and local PI receive the live database login
and password. Passwords were issued following hierarchy,
depending on the role of each staff in the study. For instance,
a local assistant only had access to data of the correspondent
centre, and not to full data.
It is noteworthy that no matter how well-planned a study
is, there are possible surprises and challenges while the
study is running. In our case, an important fact that could
potentially have an impact on the cohort was the Zika virus
outbreak that occurred in the country from 2015 to 2016 [18,
19]. As soon as the issue arose, the steering committee decided
to include variables that could address the occurrence of the
infection, such as history of fever, exanthema, conjunctivitis,
and fetal malformations [18, 19]. A few of these variables
were already part of routine collection. Nevertheless, the
centres were further contacted to pay careful attention to
these variables.
3.2. Running. We regard the onset of participant recruitment
as the key phase of a prospective study. Breaking through
the barrier of initial inertia, reaching the expected enrolment
rate, and ensuring that trained procedures are adequately
employed are the first challenges to overcome. Figure 2
demonstrates the enrolment rate of Preterm SAMBA study.
Set points, defined as A, B, C, D, and E in the figure, are most
important to understand how enrolment progress occurred.
We decided to first run the study in only one centre and
chose the coordinating centre (A–Figure 2). We were able
to monitor the database, recruitment strategies and standard
procedures, learn the proper approach to eligible women
who might participate in the cohort study with biobank
sample collection and the identification and management of
potential barriers. This experience enabled more effective on-
site training sessions of the remaining participating centres
in the following months (months between A and B –
Figure 2). As soon as all participating centres started running
the project, fortunately it did not take long to reach the
expected enrolment rate plateau (B–Figure 2). There were
three moments of noticeable decrease in enrolment rates (C,
D, and E–Figure 2). Reasons for the decreased inclusion rate
of participants in these periods were as follows: C–temporary
absence of one of the two research assistants in one centre and
a hospital staff strike in another centre; D–change of research
assistants in two participating centres and a technical issue
with the freezer in one of these centres (new equipment had
to be bought); E–a decrease in enrolment rate was evident
in the last few months of the study, most likely due to the
long period of data collection (over two years) and distance
from sites where visits or group meetings took place. We
believe that constant monitoring and surveillance, not only
remote feedback, are important to maintain the inclusion
rate of cases in such cohorts. Furthermore, ongoing shifts
in initially defined strategies to identify and recruit eligible
women should also be considered.
Television, radio, and newspaper media and a website
containing general information about the study, profile of
eligible women, and contact of all participating centres were
the main strategies employed to draw attention to the project
and reach a local and regional audience.
A general project manager was designated to perform
continuous monitoring of quality control parameters (data
and sample collection; sample processing and storage), mon-
itoring of freezer temperature records, inclusion, and loss
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to follow-up rates and inconsistent dataset. Two or three
monitoring visits were made to each centre during the study
to provide feedback on study procedures, difficulties, and
barriers to run the study and repeat some training sessions,
according to the performance of the centre and the evaluation
of the monitor. A standard monitoring report was written
after each visit and shared with all local researchers, assistants
and also the coordinating centre, to register established
commitments and decision making on how to overcome
difficulties encountered. Main parameters reported were the
number of included participants permonth, loss to follow-up,
missing data, data inconsistencies, SPREC (Standard PREan-
alytical Code) pre-analytical quality parameters for biological
samples [20], number of aliquots generated per tube, occur-
rence of fibrin, time between collection and storage, strategies
for identifying eligible women, and others. In addition to
on-site monitoring visits, several web-conference meetings
were performed to discuss the details of study progress and
data inconsistencies, enabling continuous monitoring and
a learning atmosphere which facilitated the identification
and correction of human errors and unproductive work
processes.
4. Discussion
4.1. Monitoring. An open, two-way communication between
research assistants of all participating centres and the gen-
eral study monitor was of the utmost importance for the
establishment of an effective organisation and coordination
of the study. We did not expect the lack of mistakes dur-
ing procedures or human errors discordant from standard
protocols. Nevertheless, it is not only important to prevent
these errors, but also to recognise, report, and adequately
record the issues. It is helpful to accept errors in a nonpunitive
atmosphere to enhance the confidence of collaborators. In
terms of communication, cell-phone group chats were the
quickest and most objective method employed to assure
clear and quick-response communication. Following ethical
principles, no data of participants were ever shared through
message chats.
The database system was developed in the MedSciNet
platform, a resourceful and very helpful online system for
study management. It securely links clinical data to biobank
data, providing hierarchical access, a biosample tracking
system, and multiple functions for data monitoring. At the
end of the study, the system provides a case-control function
through which the user can design clinical experiments,
selecting women whose sample positions will be provided.
According to study protocol, all women who were invited
to participate in the study and refused to undergo complete or
partial sample collection were properly registered. Contrary
to what we had anticipated, eligible women rarely declined
or reported feeling uncomfortable with blood and/or hair
collection.
Regardless of research team support or antenatal care
provided by the participating institution, a few women
preferred to maintain their antenatal care visits in primary
healthcare facilities or continue with their own private
doctors. Reasons were either emotional because of a good
relationship previously established with healthcare providers
or more practical due to a closer distance from the primary
care unit. This caused a little but noticeable impact on rates of
inclusion and loss to follow-up, owing to delays in attending
scheduled visits for sample collection. In addition, the staff
found it a much more difficult and time-consuming task
to complete information on women delivering outside the
participating facility, and required specific local strategies.We
noticed that centres which provided ANC visits had better
performance in rates of inclusion and loss to follow-up.
Public health facilities where eligible women were iden-
tified and invited to participate had different reactions to
the study. Some units were helpful and highly committed
to the task, facilitating study processes and establishing
clear boundaries between research and healthcare activi-
ties. According to strategies designed to ascertain adequate
follow-up of included cases, the centres were encouraged to
provideANC support. Although complete healthcare was not
the responsibility of the study, as previously mentioned, the
proportion of women who agreed to participate and adhere
to the study was traditionally higher in centres that offer a
personalised ANC assistance.
Regardless of the ANC provided, research assistants were
trained to adequately report several maternal and perinatal
outcomes. Standard outcomes—PE (pre-eclampsia), GDM
(gestational diabetes mellitus), PTB (preterm birth), and FGR
(fetal growth restriction)—were consistently checked against
previously standardised diagnostic criteria. Retrospective
data review to confirm or rule out an outcome can be a chal-
lenge, since it may underestimate or overestimate the inci-
dence of the outcome. Taking into account GDM, PTB, FGR,
and PE,we believe that PE is themost challenging outcome to
review and double-check. Registration of high blood pressure
levels and urine protein values during study visits might not
suffice to assure its occurrence [21]. Participating institutions
have to follow an adequate standard obstetric protocol to
ensure that late pregnancy and delivery/postpartum data
will be appropriate to confirm PE cases. Nonstandardised
recording may introduce bias and generate uncertainty with
compromised data. In summary, the concept “do it right the
first time” is legitimate and strongly recommended, as well as
the application of international standard definitions during
the study protocol. For these data, it is also important to
know the clinical protocol of each institution and reinforce
the importance of its use.
The provision of national and international biosample
transport was planned in two steps. First, for national sample
arrangement, each participating centre sent biosamples to
the coordinating centre when 60% of the sample size was
attained. Then, a second transport was arranged, containing
the remaining samples. After shipment from participating
centres arrived, the position of each cryobox containing
biosamples was updated in the database system, according
to the freezer of the coordinating centre. Transportation
was provided by an experienced company in compliance
with IATA (International Air Transport Association) and
international ethical regulations. Samples were maintained
in dry ice and monitored by a temperature data logger
in each parcel. The preparation for international shipping
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entailed further splitting of the samples into International
Biobank and Biobank Brazil, as previously detailed. The first
international transport contained 80% of the International
Biobank samples. Consequently, the second contained 20%
of samples.
The coordinating centre held a final meeting with all
local investigators, research assistants and collaborators to
discuss the plan for analysis of primary and secondary
outcomes. The participation of all collaborators from all
participating centres was truly important not only to put into
practice the opportunity to collaborate among all researchers
and assistants involved in the study but also extend the
exploration of secondary analysis by using a comprehensive
dataset. Investigators that built their careers in different areas
of maternal and perinatal health research were able to share
their experience and suggest innovative approaches to exam-
ine some specific complications that occur during pregnancy.
Moreover, participating centres of the BrazilianNetwork con-
tributed to the discussion about the implementation of the
next big study, termed the Maternal Actigraphy Exploratory
Study–I (MAES-I). The future study is an extension of the
Brazilian multicentre cohort study. It will investigate physical
activity and sleep patterns throughout pregnancy, in asso-
ciation with maternal complications using actigraphy data
(study protocol to be published). Human and technological
resources allocated for the Brazilian multicentre cohort using
biobank resources may facilitate the implementation of new
studies and application of innovative approaches including
wearable technologies, such as the actigraphy device to
monitor women during pregnancy.
5. Conclusions
Planning, implementing and running a multicentre study
with standardised clinical data and biosample collection is
challenging, although possible in low-income and middle-
income settings. Proper funding, with a detailed developed
proposal and well-established network, is pivotal to the
development of such an initiative. Enhancement of capacity
and training in settings most commonly affected by the
burden of disease in maternal and perinatal health will
strengthen findings and provide a venue for future research.
The Brazilian Network, created almost a decade ago, with
prior conduction of successful studies was fundamental to
support the current initiative. Furthermore, funders willing
to collaborate throughout the study create an opportunity
for more than study results and reports. There is room
for more effective learning to disseminate findings, raise
awareness about research impact, and add new perspectives
and collaborations.
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